Issue 15, 2017, Issue in Progress
From the journal:

RSC Advances

Correction: Novel metal chelators thiosemicarbazones with activity at the σ2 receptors and P-glycoprotein: an innovative strategy for resistant tumor treatment

Maria Laura Pati,ab   Mauro Niso,a   Savina Ferorelli,a   Carmen Abate*a  and  Francesco Berardia  

* Corresponding authors

a Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari ALDO MORO, Via Orabona 4, I-70125 Bari, Italy
E-mail: carmen.abate@uniba.it
Fax: +39-080-5442231
Tel: +39-080-5442750

b Division of Hepatobiliary, Pancreatic, and Gastrointestinal Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA

Abstract

Correction for ‘Novel metal chelators thiosemicarbazones with activity at the σ2 receptors and P-glycoprotein: an innovative strategy for resistant tumor treatment’ by Maria Laura Pati et al., RSC Adv., 2015, 5, 103131–103146.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C7RA90009K
Article type
Correction
Submitted
23 Jan 2017
Accepted
23 Jan 2017
First published
30 Jan 2017
This article is Open Access
Creative Commons BY license

RSC Adv., 2017,7, 9078-9078

Permissions

Request permissions

Correction: Novel metal chelators thiosemicarbazones with activity at the σ2 receptors and P-glycoprotein: an innovative strategy for resistant tumor treatment

M. L. Pati, M. Niso, S. Ferorelli, C. Abate and F. Berardi, RSC Adv., 2017, 7, 9078 DOI: 10.1039/C7RA90009K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements